View in EDS

Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2.

Saved in:
Bibliographic Details
Title: Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2.
Authors: Muñoz J; Banner MD Anderson Cancer Center, Gilbert, AZ, USA.; Mayo Clinic, Pheonix, AZ, USA., Locke FL; Moffitt Cancer Center, Tampa, FL, USA., Reagan PM; University of Rochester School of Medicine, Rochester, NY, USA., Goy A; John Theurer Cancer Center, Hackensack, NJ, USA., Jacobson CA; Dana-Farber Cancer Institute, Boston, MA, USA., Hill BT; Cleveland Clinic Foundation, Cleveland, OH, USA., Timmerman JM; UCLA David Geffen School of Medicine, Los Angeles, CA, USA., Flinn IW; Tennessee Oncology & One Oncology, Nashville, TN, USA., Miklos DB; Stanford University, Stanford, CA, USA., Pagel JM; Swedish Cancer Institute, Seattle, WA, USA., Kersten MJ; Amsterdam UMC, University of Amsterdam Cancer Center, Amsterdam, Netherlands., Forcade E; Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Pessac, France., Topp MS; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany., Houot R; CHU Rennes, Université Rennes, Inserm & EFS, Rennes, France., Beitinjaneh A; University of Miami, Miami, FL, USA., Zheng D; Kite, a Gilead Company, Santa Monica, CA, USA., Chang M; Kite, a Gilead Company, Santa Monica, CA, USA., Zhang W; Kite, a Gilead Company, Santa Monica, CA, USA., Shen RR; Kite, a Gilead Company, Santa Monica, CA, USA., Khalid RD; Kite, a Gilead Company, Santa Monica, CA, USA., Kloos I; Kite, a Gilead Company, Santa Monica, CA, USA., Wang ML; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org.
Source: Journal of hematology & oncology [J Hematol Oncol] 2026 Apr 27; Vol. 19 (1). Date of Electronic Publication: 2026 Apr 27.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42036693
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Muñoz+J%22">Muñoz J</searchLink>; Banner MD Anderson Cancer Center, Gilbert, AZ, USA.; Mayo Clinic, Pheonix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Locke+FL%22">Locke FL</searchLink>; Moffitt Cancer Center, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Reagan+PM%22">Reagan PM</searchLink>; University of Rochester School of Medicine, Rochester, NY, USA.<br /><searchLink fieldCode="AU" term="%22Goy+A%22">Goy A</searchLink>; John Theurer Cancer Center, Hackensack, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Jacobson+CA%22">Jacobson CA</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hill+BT%22">Hill BT</searchLink>; Cleveland Clinic Foundation, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Timmerman+JM%22">Timmerman JM</searchLink>; UCLA David Geffen School of Medicine, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Flinn+IW%22">Flinn IW</searchLink>; Tennessee Oncology & One Oncology, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Miklos+DB%22">Miklos DB</searchLink>; Stanford University, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pagel+JM%22">Pagel JM</searchLink>; Swedish Cancer Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Kersten+MJ%22">Kersten MJ</searchLink>; Amsterdam UMC, University of Amsterdam Cancer Center, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Forcade+E%22">Forcade E</searchLink>; Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Pessac, France.<br /><searchLink fieldCode="AU" term="%22Topp+MS%22">Topp MS</searchLink>; Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Houot+R%22">Houot R</searchLink>; CHU Rennes, Université Rennes, Inserm & EFS, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Beitinjaneh+A%22">Beitinjaneh A</searchLink>; University of Miami, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Zheng+D%22">Zheng D</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chang+M%22">Chang M</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+W%22">Zhang W</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shen+RR%22">Shen RR</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Khalid+RD%22">Khalid RD</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kloos+I%22">Kloos I</searchLink>; Kite, a Gilead Company, Santa Monica, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wang+ML%22">Wang ML</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101468937%22">Journal of hematology & oncology</searchLink> [J Hematol Oncol] 2026 Apr 27; Vol. 19 (1). <i>Date of Electronic Publication: </i>2026 Apr 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Biomed+Central%22">Biomed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101468937 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1756-8722 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217568722%22">17568722 </searchLink><i>NLM ISO Abbreviation: </i>J Hematol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42036693
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13045-026-01797-4
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Muñoz J
      – PersonEntity:
          Name:
            NameFull: Locke FL
      – PersonEntity:
          Name:
            NameFull: Reagan PM
      – PersonEntity:
          Name:
            NameFull: Goy A
      – PersonEntity:
          Name:
            NameFull: Jacobson CA
      – PersonEntity:
          Name:
            NameFull: Hill BT
      – PersonEntity:
          Name:
            NameFull: Timmerman JM
      – PersonEntity:
          Name:
            NameFull: Flinn IW
      – PersonEntity:
          Name:
            NameFull: Miklos DB
      – PersonEntity:
          Name:
            NameFull: Pagel JM
      – PersonEntity:
          Name:
            NameFull: Kersten MJ
      – PersonEntity:
          Name:
            NameFull: Forcade E
      – PersonEntity:
          Name:
            NameFull: Topp MS
      – PersonEntity:
          Name:
            NameFull: Houot R
      – PersonEntity:
          Name:
            NameFull: Beitinjaneh A
      – PersonEntity:
          Name:
            NameFull: Zheng D
      – PersonEntity:
          Name:
            NameFull: Chang M
      – PersonEntity:
          Name:
            NameFull: Zhang W
      – PersonEntity:
          Name:
            NameFull: Shen RR
      – PersonEntity:
          Name:
            NameFull: Khalid RD
      – PersonEntity:
          Name:
            NameFull: Kloos I
      – PersonEntity:
          Name:
            NameFull: Wang ML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 04
              Text: 2026 Apr 27
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1756-8722
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of hematology & oncology
              Type: main
ResultId 1